What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Chemotherapy
Internal medicine, Surgery, Oncology, Chemotherapy and Pathology are her primary areas of study.
As part of her studies on Internal medicine, she often connects relevant subjects like Gastroenterology.
As a part of the same scientific family, Lisa M. DeAngelis mostly works in the field of Surgery, focusing on Metastasis and, on occasion, Neoplastic meningitis.
Her work carried out in the field of Oncology brings together such families of science as Clinical trial, Phases of clinical research, Temozolomide, Brain tumor and Bevacizumab.
Her Chemotherapy study combines topics in areas such as Survival rate, Regimen and Lymphoma.
Her Pathology study combines topics from a wide range of disciplines, such as Magnetic resonance imaging, Central nervous system disease and Glioma.
Her most cited work include:
- Glioblastoma and Other Malignant Gliomas: A Clinical Review (1237 citations)
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (1106 citations)
- Radiation-induced dementia in patients cured of brain metastases. (758 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Oncology, Surgery, Chemotherapy and Cancer.
The Internal medicine study combines topics in areas such as Gastroenterology and Glioma.
Her Oncology research includes elements of Methotrexate, Phases of clinical research, Survival rate, Brain tumor and Disease.
Her Surgery study frequently draws connections between adjacent fields such as Clinical trial.
Her Cancer research is multidisciplinary, relying on both Malignancy, Epidemiology, Stroke, Ischemic stroke and Neurology.
The study incorporates disciplines such as Combined Modality Therapy and Incidence in addition to Primary central nervous system lymphoma.
She most often published in these fields:
- Internal medicine (58.70%)
- Oncology (36.41%)
- Surgery (28.44%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (58.70%)
- Oncology (36.41%)
- Cancer (25.18%)
In recent papers she was focusing on the following fields of study:
Lisa M. DeAngelis mostly deals with Internal medicine, Oncology, Cancer, Glioma and Lymphoma.
Her research investigates the link between Internal medicine and topics such as Brain tumor that cross with problems in Survival rate.
Lisa M. DeAngelis has included themes like Executive functions, Apolipoprotein E, Disease and Radiation therapy in her Oncology study.
Her Glioma research includes themes of Cohort and Pathology.
Her Lymphoma research is multidisciplinary, incorporating elements of ThioTEPA, Methotrexate and Ibrutinib.
Her research investigates the connection with Myocardial infarction and areas like Diagnosis code which intersect with concerns in Surgery.
Between 2015 and 2021, her most popular works were:
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (1106 citations)
- Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia. (305 citations)
- Risk of Arterial Thromboembolism in Patients With Cancer (225 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Lisa M. DeAngelis mainly focuses on Internal medicine, Oncology, Cancer, Chemotherapy and Glioma.
Her Gastroenterology research extends to Internal medicine, which is thematically connected.
Her Oncology study integrates concerns from other disciplines, such as Clinical trial, Mutation, Executive functions, Cognition and Lung.
The various areas that Lisa M. DeAngelis examines in her Cancer study include Neurotoxicity, Myocardial infarction and Ischemic stroke.
Her Chemotherapy study incorporates themes from Neurology and Radiation therapy.
Lisa M. DeAngelis combines subjects such as Glioblastoma, Isocitrate dehydrogenase, Neoplasm staging and Pathology with her study of Glioma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
